Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) dropped 12.7% during mid-day trading on Tuesday . The stock traded as low as $1.67 and last traded at $1.87. Approximately 7,500 shares traded hands during mid-day trading, an increase of 163% from the average daily volume of 2,852 shares. The stock had previously closed at $2.1420.
Ascletis Pharma Stock Down 12.7%
The firm’s 50 day moving average is $2.03 and its 200-day moving average is $1.84.
About Ascletis Pharma
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
See Also
- Five stocks we like better than Ascletis Pharma
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
